Yiran Gan 4/8/25 Yiran Gan 4/8/25 Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Increased Levels of Plasma Alzheimer’s Disease Biomarkers and Their Associations with Brain Structural Changes and Carotid Intima-Media Thickness in Cognitively Normal Obstructive Sleep Apnea Patients Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Prediction of Cognitive Degeneration in Parkinson’s Disease Patients Using a Machine Learning Method Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Real-time changes in the AC magnetic susceptibility of reagents during immunomagnetic reduction assays Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Detection and assessment of alpha-synuclein in Parkinson disease Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study Read More Newer Posts Older Posts
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Increased Levels of Plasma Alzheimer’s Disease Biomarkers and Their Associations with Brain Structural Changes and Carotid Intima-Media Thickness in Cognitively Normal Obstructive Sleep Apnea Patients Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Prediction of Cognitive Degeneration in Parkinson’s Disease Patients Using a Machine Learning Method Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Real-time changes in the AC magnetic susceptibility of reagents during immunomagnetic reduction assays Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Detection and assessment of alpha-synuclein in Parkinson disease Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study Read More
